Precision medicine and phenotypes, endotypes, genotypes, regiotypes, and theratypes of allergic diseases
Ioana Agache1 and Cezmi A. Akdis2,3
1Transylvania University, Faculty of Medicine, Brasov, Romania.
2Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
3Christine Kühne – Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Address correspondence to: Cezmi A. Akdis, Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270, Davos, Switzerland. Phone: 41.81.410.08.48; Email: akdisac@siaf.unizh.ch.
Find articles by Agache, I. in: JCI | PubMed | Google Scholar
1Transylvania University, Faculty of Medicine, Brasov, Romania.
2Swiss Institute of Allergy and Asthma Research (SIAF), University of Zurich, Davos, Switzerland.
3Christine Kühne – Center for Allergy Research and Education (CK-CARE), Davos, Switzerland.
Address correspondence to: Cezmi A. Akdis, Swiss Institute of Allergy and Asthma Research (SIAF), Obere Strasse 22, CH-7270, Davos, Switzerland. Phone: 41.81.410.08.48; Email: akdisac@siaf.unizh.ch.
Find articles by
Akdis, C.
in:
JCI
|
PubMed
|
Google Scholar
|
First published March 11, 2019 - More info
© 2019 American Society for Clinical Investigation
A rapidly developing paradigm for modern health care is a proactive and individualized response to patients’ symptoms, combining precision diagnosis and personalized treatment. Precision medicine is becoming an overarching medical discipline that will require a better understanding of biomarkers, phenotypes, endotypes, genotypes, regiotypes, and theratypes of diseases. The 100-year-old personalized allergen-specific management of allergic diseases has particularly contributed to early awareness in precision medicine. Polyomics, big data, and systems biology have demonstrated a profound complexity and dynamic variability in allergic disease between individuals, as well as between regions. Escalating health care costs together with questionable efficacy of the current management of allergic diseases facilitated the emergence of the endotype-driven approach. We describe here a precision medicine approach that stratifies patients based on disease mechanisms to optimize management of allergic diseases.
- Purchase this article
- $10
- Purchasing this article will give you full access for the calendar year.
- Purchase Site Pass
- $25
- This will give you access to every article on the site for 24 hours.
- Online subscription
- $95
- Individual online subscriptions give you full online access for the calendar year.
- Print subscription
- $795
- Individual print subscriptions give you the print journal and full online access for the year.
- JCI This Month subscription
- $125
- JCI This Month is a 16- to 20-page overview of the articles published each month
- Subscribing to JCI This Month also gives subscribers full online access for the calendar year.
- *Price outside U.S. and Canada: $225.
Copyright © 2019 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)